CIK 0001636651 · Non-accelerated filer<br>Smaller reporting company
Ovid Therapeutics Inc.
Sign in to watch- Ticker
- OVID
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465270895
- Phone
- 212-776-4381
- Business address
- 441 NINTH AVENUE, 14TH FLOOR, NEW YORK, NY, 10001
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 61 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-23 | Tardio Jason Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +175,000 | 175,000 | ||
| 2023-02-23 | Rona Jeffrey A CBFO | Grant or award · Stock Option (Right to Buy) | +175,000 | 175,000 | ||
| 2023-02-23 | Poole Robert Michael Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2023-02-23 | Perone Thomas Michael General Counsel, Secretary | Grant or award · Stock Option (Right to Buy) | +175,000 | 175,000 | ||
| 2023-02-23 | LEVIN JEREMY M CEO | Grant or award · Stock Option (Right to Buy) | +600,000 | 600,000 | ||
| 2023-02-23 | Friedman Bart Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2023-02-23 | Fitzgerald Kevin Joseph Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2023-02-23 | Duncan Barbara Gayle Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2023-02-23 | Bernstein Karen Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2022-09-12 | Tardio Jason Chief Operating Officer | Sale | −17,344 | $2.15 | $37K | 0 |
| 2022-07-01 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Other disposition | −5,750,000 | 0 | ||
| 2022-07-01 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Other acquisition | +5,750,000 | 5,750,000 | ||
| 2022-07-01 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Other disposition · Series A Convertible Preferred Stock | −1,250 | 0 | ||
| 2022-07-01 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Other acquisition · Series A Convertible Preferred Stock | +1,250 | 1,250 | ||
| 2022-04-08 | Friedman Bart Director | Grant or award · Stock Option (Right to Buy) | +69,424 | 69,424 | ||
| 2022-04-08 | Tardio Jason Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +87,498 | 87,498 | ||
| 2022-04-08 | Tardio Jason Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2022-04-08 | LEVIN JEREMY M CEO | Grant or award · Stock Option (Right to Buy) | +423,244 | 423,244 | ||
| 2022-04-08 | Rona Jeffrey A CBFO | Grant or award · Stock Option (Right to Buy) | +194,399 | 194,399 | ||
| 2022-04-08 | Rona Jeffrey A CBFO | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 |
Page 4 of 7 · 123 trades